Amritsagar Formulation Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
as on 30-12-2024
- Paid Up Capital ₹ 50.00 K
as on 30-12-2024
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
as on 30-12-2024
- Satisfied Charges ₹ 0.50 M
as on 30-12-2024
- Revenue 24.32%
(FY 2022)
- Profit -4110.37%
(FY 2022)
- Ebitda -56.17%
(FY 2022)
- Net Worth -37.24%
(FY 2022)
- Total Assets 94.49%
(FY 2022)
About Amritsagar Formulation
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 50.00 K .
The company currently has active open charges totaling ₹1.00 M. The company has closed loans amounting to ₹0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Ankit Sharma, Virendra Sharma, and Zameer Ahmed serve as directors at the Company.
- CIN/LLPIN
U24117UP2019PTC112735
- Company No.
112735
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jan 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Amritsagar Formulation?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Virendra Sharma  | Director | 23-Jan-2019 | Current |
| Ankit Sharma | Director | 23-Jan-2019 | Current |
| Zameer Ahmed | Director | 23-Jan-2019 | Current |
Financial Performance of Amritsagar Formulation.
Amritsagar Formulation Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 24.32% increase. The company also saw a substantial fall in profitability, with a 4110.37% decrease in profit. The company's net worth observed a substantial decline by a decrease of 37.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amritsagar Formulation?
In 2022, Amritsagar Formulation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 23 Aug 2023 | ₹1.00 M | Open |
Canara Bank Creation Date: 25 Mar 2022 | ₹0.50 M | Satisfied |
How Many Employees Work at Amritsagar Formulation?
Unlock and access historical data on people associated with Amritsagar Formulation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amritsagar Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amritsagar Formulation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
